Silo Pharma closes private placement, expects about $815,000 in net proceeds
SILO•Silo Pharma closed a private placement on Nov. 6, 2026, and expects net proceeds of approximately $815,000. The placement covered 136,005 common shares at $1.50 each and pre-funded warrants for 430,661 shares at $1.4999 per warrant.
1. Placement details
Silo Pharma closed the private placement on Nov. 6, 2026, under purchase agreements dated Nov. 5. The pre-funded warrants are immediately exercisable at $0.0001 per share. The company intends to use the net proceeds for working capital and general corporate purposes.
